Proposed Maximum Aggregate Value of Transaction | Fee Rate | Amount of Filing Fee | |
| Fees to be Paid | $970,986,260.38(1) | 0.00015310 | $148,658.00(2) |
| Fees Previously Paid | $0 | $0 | |
| Total Transaction Valuation | $970,986,260.38 | ||
| Total Fees Due for Filing | $148,658.00 | ||
| Total Fees Previously Paid | $0 | ||
| Total Fee Offsets | $0 | ||
| Net Fee Due | $148,658.00 |
| (1) | Estimated solely for the purpose of calculating the filing fee, the underlying value of the transaction was calculated based on the sum of (a) $200,000,000 and (b) the product of 24,530,266 Class A shares, par value $0.0001 per share (“Class A ordinary shares”), of Royalty Pharma plc multiplied by $31.43 (which is the average of the high and low share prices of the Class A ordinary shares as of February 6, 2025). |
| (2) | The amount of the filing fee, calculated in accordance with Section 14(g) of the Securities Exchange Act of 1934, as amended, was calculated by multiplying $970,986,260.38 by 0.00015310. |
